ARTICLE | Clinical News
Immunoscore Colon regulatory update
January 13, 2017 8:52 PM UTC
HalioDx launched its Immunoscore Colon diagnostic assay in Europe as an aid to assess prognosis of primary colon cancer. The product, which has CE Mark approval, is an in vitro diagnostic that measure...
BCIQ Company Profiles